Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model
Abraham Al‐Ahmad, Iqra Pervaiz, Vardan T. Karamyan
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 2
Open Access | Times Cited: 20

Showing 20 citing articles:

Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases
Xin Yi Yeo, Grace Cunliffe, Roger Ho, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 343-343
Open Access | Times Cited: 33
Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
Olivia Rice, Allison Surian, Yupeng Chen
Journal of Tissue Engineering (2022) Vol. 13
Open Access | Times Cited: 16
Substance P reversibly compromises the integrity and function of blood-brain barrier
Xin Gao, Ulvi Bayraktutan
Peptides (2023) Vol. 167, pp. 171048-171048
Open Access | Times Cited: 10
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?
Vardan T. Karamyan
Physiological Reports (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 23
Development of fluorogenic substrates for colorectal tumor-related neuropeptidases for activity-based diagnosis
N Nagano, Yuki Ichihashi, Toru Komatsu, et al.
Chemical Science (2023) Vol. 14, Iss. 17, pp. 4495-4499
Open Access | Times Cited: 7
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke
Yasaman Mehdizadeh Darban, Hamid Askari, Maryam Ghasemi‐Kasman, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 14, pp. 2368-2383
Closed Access | Times Cited: 2
Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives
Manuele Figueiredo da Silva, João Xavier de Araújo‐Júnior, Edeildo Ferreira da Silva‐Júnior, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 3, pp. 275-283
Open Access | Times Cited: 12
Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability
Md. Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 17, pp. 12705-12722
Open Access | Times Cited: 13
In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals
Saeideh Nozohouri, Shiva Hadi Esfahani, Behnam Noorani, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 7, pp. 1587-1598
Open Access | Times Cited: 9
Identification and Characterization of Two Structurally Related Dipeptides that Enhance Catalytic Efficiency of Neurolysin
Srinidhi Jayaraman, Joanna Kocot, Shiva Hadi Esfahani, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 379, Iss. 2, pp. 191-202
Open Access | Times Cited: 11
Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability
Md. Shafikur Rahman, Shiva Hadi Esfahani, Yong Zhang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 510-517
Closed Access | Times Cited: 1
A circadian clock regulates the blood-brain barrier across phylogeny
Ashley Avila, Shirley Zhang
Vitamins and hormones (2024), pp. 241-287
Closed Access | Times Cited: 1
The relationship between dietary total antioxidant capacity, clinical parameters, and oxidative stress in fibromyalgia syndrome: A novel point of view
Kübra Tel Adıgüzel, Özlem Köroğlu, Evren Yaşar, et al.
Turkish Journal of Physical Medicine and Rehabilitation (2022) Vol. 68, Iss. 2, pp. 262-270
Open Access | Times Cited: 7
Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals
Yong Zhang, Sejal Sharma, Shirisha Jonnalagadda, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 11, pp. 2747-2758
Closed Access | Times Cited: 3
Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy
Shiva Hadi Esfahani, Thomas J. Abbruscato, Paul C. Trippier, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 401-404
Open Access | Times Cited: 5
Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence
Xin Gao, Nanci Frakich, Perla Filippini, et al.
Neuropeptides (2022) Vol. 95, pp. 102265-102265
Closed Access | Times Cited: 3
SC79 promotes efficient entry of GDNF liposomes into brain parenchyma to repair dopamine neurons through reversible regulation of tight junction proteins
Xiaomei Wu, Li Wang, Kai Wang, et al.
Nano Research (2022) Vol. 16, Iss. 2, pp. 2695-2705
Closed Access | Times Cited: 3
Cellular Metabolism of Substance P Produces Neurokinin-1 Receptor Peptide Agonists with diminished cyclic AMP Signaling
Tamás Kriska, Jayashree Natarajan, Anja Herrnreiter, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C151-C167
Closed Access
Substance P in neurotrauma
Rebecca George, Justin L. Krieg, Frances Corrigan
Elsevier eBooks (2024), pp. 423-438
Closed Access
Substance P in inflammation
Sophie E. Sipprell, Ian Marriott
Elsevier eBooks (2024), pp. 291-339
Closed Access
Page 1

Scroll to top